Health equity under siege: the populist challenge to women’s health in Europe
Rachel Greenley, Anneli Uusküla, Pia Kirkegaard, Marc Bardou, Martin McKee, Marc Bardou, Marc Bardou, Berit Andersen, Pia Kirkegaard, Rikke Buus Bøje, Mette Tranberg, Rosa Legood, Anna Foss, Martin McKee, Rachel Greenley, Liu Sun, Paolo Giorgi Rossi, Luca Ghirotto

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —EU’s Horizon 2020 research and innovation programme
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGender Politics and Representation · Sex and Gender in Healthcare · Healthcare Systems and Challenges
Women in Europe have unmet needs for many preventive health services, exemplified by cervical cancer, where death rates vary at least sevenfold [1]. Despite being largely preventable through vaccination for human papillomavirus (HPV) and screening, structural barriers leave many women, such as migrants, ethnic minorities, and those in precarious circumstances, without access to services [2]. What progress has been achieved in vaccination uptake among girls and boys [3], introduction of self-sampling, and HPV testing replacing labour-intensive cytology [4], is now threatened by populist rhetoric spreading from the United States [5].The second Trump administration’s assault on science primarily targets women’s health programmes domestically [6], but the 2025 US National Security Strategy[7] and statements by Donald Trump[8] and his Vice President[9] have emboldened similar narratives in Europe. They frame preventive programmes as ‘ideological’ or ‘foreign’, rewrite legislation, and cut funding streams that dare to mention terms like diversity, women, gender, inclusion or vaccine confidence. This stifles innovation, weakens institutional capacity, and perpetuates inequities.
Safeguarding women’s health requires resilience. This requires acceptance that screening is a core element of public health, funding being diversified beyond vulnerable national budgets, and coalitions being built to defend health equity as a democratic principle. Without proactive measures, populist obstruction risks reversing hard-won gains and excluding Europe’s most vulnerable women from essential preventive care. As researchers who have documented the structural barriers facing many European women, we can identify three specific risks and outline ways to mitigate them.
These risks demand urgent action, which we address through five imperatives.
Addressing unmet needs in women’s health in Europe requires more than technical fixes; it demands political resilience. Populist narratives, amplified by U.S. rhetoric, threaten progress by delegitimising gender-specific health initiatives and obstructing policy and funding. Embedding strategies such as coalition building, inclusive communication, diversified funding, and proactive policy engagement frames preventive programmes as universal public health imperatives. Anticipating and countering ideological challenges safeguards equity, protects vulnerable populations, and upholds access to preventive care as a fundamental right rather than a political bargaining chip.
Conflict of interest: The authors all undertake research to improve women’s health, which could be adversely affected by policies pursued by radical populist politicians.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Sung H , Ferlay J, Siegel RL et al Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49.33538338 10.3322/caac.21660 · doi ↗ · pubmed ↗
- 2Greenley R , Bell S, Rigby S, CBIG-SCREEN Consortium et al Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature. Front Public Health 2023;11:1144674.37304105 10.3389/fpubh.2023.1144674 PMC 10247980 · doi ↗ · pubmed ↗
- 3Gountas I , Aman M, Alexander D et al Estimating the time required to reach HPV vaccination targets across Europe. Expert Rev Vaccines 2025;24:165–72.39269212 10.1080/14760584.2024.2402535 · doi ↗ · pubmed ↗
- 4Colonetti T , Rodrigues Uggioni ML, Meller Dos Santos AL et al Self-sampling for HPV testing in cervical cancer screening: a scoping review. Eur J Obstet Gynecol Reprod Biol 2024;296:20–51.38394715 10.1016/j.ejogrb.2024.02.032 · doi ↗ · pubmed ↗
- 5Piroddi C , Gilby L, Koivusalo M et al The hegemony of far-right populism, project 2025, and the dangers ahead for science and public health. Int J Soc Determinants Health Health Serv 2026;56:60–4.40820411 10.1177/27551938251367853 PMC 12662832 · doi ↗ · pubmed ↗
- 6Rosenthal J , Jones KB. The Trump Administration is Endangering Women’s Reproductive Health. Washington DC: Center for American Progress, 2025.
- 7The White House. National Security Strategy of the United States of America. Washington DC: The White House, 2025.
- 8Burns A. Trump thrashes european leaders in wide-ranging interview: ‘I think they’re weak’. Politico 2025. https://www.politico.com/news/2025/12/09/trump-dasha-burns-interview-europe-immigration-ukraine-00682016?nid=0000017 b-1c 0d-d 760-a 77b-9c 4da 7ed 0000&nname=canada-playbook&nrid=9daf 4c 87-224f-4b 5e-87fd-0970 feb 575bb
